Stay updated on Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, indicating a minor release or patch. This update does not modify any study details or page content.
    Difference
    0.1%
    Check dated 2026-06-28T08:36:55.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Recruitment status now indicates no longer looking for participants. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the page revision label updated from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-13T16:44:11.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5. This reflects a new version of the page on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-06-06T12:39:40.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.5.3 to v3.5.4, indicating a small software release or patch rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-05-15T23:50:02.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The site’s revision/version label at the bottom of the page was updated from **v3.5.2** to **v3.5.3**, reflecting a documentation/UI release rather than a change to the clinical trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T17:13:48.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:09:08.000Z thumbnail image

Stay in the know with updates to Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page.